Cite
Design, Synthesis, In Vitro Biological Activity Evaluation and Stabilized Nanostructured Lipid Carrier Formulation of Newly Synthesized Schiff Bases-Based TMP Moieties.
MLA
Bukhari, Syed Nasir Abbas, et al. “Design, Synthesis, In Vitro Biological Activity Evaluation and Stabilized Nanostructured Lipid Carrier Formulation of Newly Synthesized Schiff Bases-Based TMP Moieties.” Pharmaceuticals (14248247), vol. 15, no. 6, June 2022, p. 679–N.PAG. EBSCOhost, https://doi.org/10.3390/ph15060679.
APA
Bukhari, S. N. A., Zakaria, M. Y., Munir, M. U., Ahmad, N., Elsherif, M. A., Badr, R. E., Hassan, A. K., Almaaty, A. H. A., & Zaki, I. (2022). Design, Synthesis, In Vitro Biological Activity Evaluation and Stabilized Nanostructured Lipid Carrier Formulation of Newly Synthesized Schiff Bases-Based TMP Moieties. Pharmaceuticals (14248247), 15(6), 679–N.PAG. https://doi.org/10.3390/ph15060679
Chicago
Bukhari, Syed Nasir Abbas, Mohamed Y. Zakaria, Muhammad Usman Munir, Naveed Ahmad, Mervat A Elsherif, Rasha Emad Badr, Ahmad Khalaf Hassan, Ali H. Abu Almaaty, and Islam Zaki. 2022. “Design, Synthesis, In Vitro Biological Activity Evaluation and Stabilized Nanostructured Lipid Carrier Formulation of Newly Synthesized Schiff Bases-Based TMP Moieties.” Pharmaceuticals (14248247) 15 (6): 679–N.PAG. doi:10.3390/ph15060679.